US Patent 8034771 IL-1F6 polypeptides

Patent 8034771 was granted and assigned to Amgen on October, 2011 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Amgen

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8034771

Date of Patent

October 11, 2011

Patent Application Number

11900235

Date Filed

September 10, 2007

Patent Citations Received

‌

US Patent 11884719 Anti-IL-36 antibodies and methods of use thereof

‌

US Patent 11926665 Methods of treating cancer with anti-TIM-3 antibodies

‌

US Patent 11753472 Antibodies directed against T cell immunoglobulin and mucin protein 3 (TIM-3)

Patent Primary Examiner

‌

Ruixiang Li

Patent abstract

The present invention provides compositions and methods relating to IL-1Rrp2 requiring proteins.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8034771 IL-1F6 polypeptides

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API